The Relationship of Interferon Gamma +874T/A and Interleukin-10 -1082G/A Gene Polymorphism to The Recovery of Multidrug Resistant Tuberculosis Patients
DOI:
https://doi.org/10.36497/jri.v37i4.85Keywords:
MDR-TB, IFN-γ 874T/A gene polymorphism, IL-10 -1082G/A gene polymorphismAbstract
Background: Multidrug resistant (MDR) TB caused by the M.Tb strain is resistant toward at least rifampicin and isoniazid. Interferon Gamma is responsible for activating macrophages and phagocytosis for M.Tb destruction. Interleukin 10 causes a significant decrease in reactive nitrogen intermediates, increased arginase 1, and overall decreased macrophage function. Gene mutation causes IFN production by CD4 - T cells less effective and disrupts the immune response against M.Tb. There has been no research on the relationship between IFN-γ and IL-10 gene polymorphisms with TB recovery in Indonesia, especially in patients with MDR-TB. The aim of this study is to determine gene polymorphism relationship of IFN-γ +874T/A and IL-10 -1082G/A with MDR-TB recovery. Methods: This study was a non-experimental clinical trial with a retrospective cohort design. The study was conducted on 105 MDR-TB patients treated in dr. Moewardi Hospital between January 2011-June 2014 consists of 84 recovered patients and 21 patients died/failed. Results: Gene polymorphism of IFN-γ +874T/A was obtained OR=0.703 (0.265-1.863) and P=0.477 which mean IFN-γ +874 T/A gene was not related to recovered case of MDR-TB. The IL-10 -1082G/A gene obtained the value of OR=0.657 (0.173-2.491) and the value P=0.785 which means that IL-10 -1082G/A is not related to the MDR-TB case recovery. Conclusions: There is no relationship of IFN-γ + 874T/A and IL-10 -1082G/A gene polymorphisms in the recovery of MDR-TB patients. (J Respir Indo. 2017; 37(4): 299-306)Downloads
References
Palomini JC, Martin A. Drug resistance mechanisms in mycobacterium tuberculosis. Antibiotics (Basel). 2014;3(3):317-40.
Perhimpunan Dokter Paru Indonesia. Pedoman tatalaksana infeksi TB laten. Jakarta: PDPI; 2016.
Gunther G. Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges. Clin Med. 2014;14(3):279-85.
Dheda K, Schwander SK, Zhu B, van Zyl-Smit R, Zhang Y. The immunology of tuberculosis: from bench to bedside. Respirology. 2010;15(3):433-50.
Schluger NW, Rom WN. The host immune response to tuberculosis. Am J Respir Crit Care Med. 1998;157(3 Pt 1):679-91.
Guo S, Zhao J. Immunotherapy for tuberculosis: what’s the better choice? Front Biosci (Landmark Ed). 2012;17:2684-90.
Redford PS, Murray PJ, O’Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 2011;4(3):261-7.
Karki R, Pandya D, Elston RC, Ferlini C. Defining “mutation” and “polymorphism” in the era of personal genomics. BMC Medical Genomics. 2015;8(37):1-8.
Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet. 2000;58(4):250-64.
Fol M, Druszczynska M, Wlodarczyk M, Ograczyk E, Rudnicka W. Immune response gene polymorphism in tuberculosis. Acta Biochim Pol. 2015;62(4):633-40.
Amirzargar AA, Rezaei N, Jabbari H, Danesh AA, Khosravi F, et al. Cytokines genes polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw. 2006;17(2):84-9.
Lee WS, Chuang TY, Huang HH, Lee KF, Chen TT, et al. Interferon gamma polymorphisms associated with susceptibility to tuberculosis in a Han Taiwanese population. J Microbiol Immunol Infect. 2015;48(4):376-80.
Asgharzadeh M, Ghorghanlu S, Rashedi J, Mahdavi Poor B, Khaki-Khatibi F, et al. Association of promoter polymorphism of interleukin-10 and interferon-gamma with tuberculosis in Azeri population of Iran. Iran J Allergy Asthma Immunol. 2016;15(3):167-73.
Oral HB, Budak F, Uzaslan EK, Baştürk B, Bekar A et al. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokine. 2006;35(3-4):143-7.
Sawitri NE, Reviono, Suradi, Prasetyo AA. Polimorfisme gen IL-10-1082 G/A sebagai faktor kerentanan pejamu pada pasien tuberkulosis multidrug resistant. J Respir Indo. 2016;36(1):1-10.
Kementerian Kesehatan Republik Indonesia. Pedomam manajemen terpadu pengendalian tuberkulosis resistan obat. Jakarta: Kementerin Kesehatan RI; 2013. p.27-44.
Vignal A, Milan D, Eggen A, Eggen A. A review on SNP and other types of molecular markers and their use in animal genetics. Genet Sel Evol. 2002;34(3):275-305.
Wang S, Carruthers B, Turner J. The influence of increasing age on susceptibility of the elderly to tuberculosis. Open Longevity Science. 2012;6(1):73-82.
World Health Organization. Guideline: nutritional care and support for patients with tuberculosis. Geneva: World Health Organization; 2013. p.15-27.
Baghai P, Tabarsi P, Ehsan C, Novin A, Alipanah N, et al. Risk factors associated with multidrug-resistant. Tannafos. 2009;8(3):17-21.
Thomas A, Goppi PG, Santa T, Chandrasekaran V, Subramani R, et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programe in South India. Inter J Tuberc Lung Dis. 2005;9(5):556-61.
Herr C, Beisswenger C, Hess C, Kandler K, Suttorp N, et al. Suppression of pulmonary innate host defence in smokers. Thorax. 2008;64(2):144-9.
Sharma SK, Mohan A. Multidrug resistant tuberculosis. Indian J Med Res. 2004;120(4):354-76.
Gandhi NR, Nunn P, Dheeda K, Schaaf HS, Zignol M, et al. Multidrug-resistant and extensively drug resistant tuberculosis: threat to global control of tuberculosis. Lancet. 2010;375(9728):1830-43.
Manderuelo DL, Arnalich F, Serantes R, González A, Codoceo R, et al. Interferon-γ and interleukin-10 gene polymorphism in pulmonary tuberculosis. Am J Respir Crit Care Med. 2003;167(7):970-5.
Ahmad S. Pathogenesis, immunology, and diagnosis of latent mycobacterium tuberculosis infection. Clinical and Developmental Immunology. 2011;1:1-17.
Raja A. Immunology of tuberculosis. Indian J Med Res. 2004;120(4):213-32.
Moura EP, Toledo VP, Oliveira MH, Spíndola-de-Miranda S, Andrade HM. Pulmonary tuberculosis: evaluation of interferon-γ levels as an immunological healing marker based on the response to the bacillus calmette-guerin. Mem Inst Oswaldo Cruz. 2004;99(3):283-7.
Cavalcanti YVN, Brelaz MCA, Ferraz JC, et al. Role of TNF-alpha, IFN-gamma, and IL-10 in the development pulmonary tuberculosis. Pulmonary Medicine. 2012:1-7.
Ke Z, Yuan L, Ma J, Zhang X, Guo Y, et al. IL-10 polymorphisms and tuberculosis susceptibility: an update meta analysis. Yonsei Medical Journal. 2015;56(5):1274-87.
Chelluri EP, Chelluri LK, Pawar S, Debnath T, Reddy. IL-10 polymorphisms in inflammatory and infectious respiratory diseases with seropositive H. Pylori. Biology. 2013;3(4):1-10.
Abdalla AE, Lambert N, Duan X, Xie J. Interleukin-10 family and tuberculosis: an old story renewed. Int J Biol Sci. 2016;12(6):710-7.
Downloads
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
